Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 277 Results
Age
Type
Conditions or Disease:

Safety and efficacy of AB-1003 in subjects (ages 18-65) with LGMD2I/R9 impacting FKRP

Tahseen Mozaffar

  • OPEN TO ACCRUAL

R5459-RT-1944: Study for Desensitization of Chronic Kidney Disease in Adult Patients in Need of a Ki

Robert Redfield III

  • OPEN TO ACCRUAL

PhI/IINivolumab+-Ipilimumabw/MultiFractionStereotacticRadiosurRecurHighGradeRadiationRelapsedMeningi

Aaron Simon

  • OPEN TO ACCRUAL

Study Evaluating Variability, Reliability, and Compliance for the Parkinson s Disease Diary

Claire Henchcliffe

  • OPEN TO ACCRUAL

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors

Michael A Hoyt

  • OPEN TO ACCRUAL

PhIII HighFiveTrial Five Fraction Rad for HighRisk Prostate Ca

Steven Neema Seyedin

  • OPEN TO ACCRUAL

Study To Evaluate The Efficacy And Safety Of Mls-101 In Subjects With Uncontrolled Hypertension

Ekamol Tantisattamo

  • OPEN TO ACCRUAL

A Phase 2 Clinical Study to Assess the Safety and Efficacy of Deucravacitinib in Participants with

Michelle Min

  • OPEN TO ACCRUAL

Assess Rocatinlimab in Adolescent Subjects Aged 12 to 17 With Moderate-to-severe Atopic Dermatitis

Michelle Min

  • OPEN TO ACCRUAL

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Michelle Min

  • OPEN TO ACCRUAL

PhII AFM13Comb.w/Allogenic AB-101 in Pts.w/Recurrent/RefractoryHodgkinLymph/CD30-Pos.PeriT-CellLymph

Lauren C Pinter-Brown

  • OPEN TO ACCRUAL

Ph Ib/II TAK-981 + Pembrolizumab Combination in Patients w/ Select Advanced or Met Solid Tumors

Krishnansu Tewari

  • OPEN TO ACCRUAL

PhIb BI 764532 Given Monotherapy Administered by Repeated Intravenous Infusions in Pa w/Glioma DLL3

Daniela Bota

  • OPEN TO ACCRUAL

PhII EvalEfficSaf&Impact TuMicroen CombTocilizumabAtezolizumab&FractioStereotac Radiothe Recur Gliob

Xiao-Tang Kong

  • OPEN TO ACCRUAL

PhII Random StudyNeoadj Pembrolizumab Alone orComb w/CMP-001 Pa w/Operable Mela: Effic&Biomark Study

Thuy Tran

  • OPEN TO ACCRUAL

Pilot to Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Misako Nagasaka

  • OPEN TO ACCRUAL

PhIIIMirvetuximabSoravtansineCombW/BevacizumabVSBevacizumab PaW/FrA+After2ndLine PlatinumChemo +Bev

Krishnansu Tewari

  • OPEN TO ACCRUAL